Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Lene Kjældgaard

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Immunology|June 24, 2018
Amyotrophic lateral sclerosis: The complement and inflammatory hypothesisAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
BMJ Open|August 8, 2020
Amyotrophic lateral sclerosis and the innate immune system: protocol for establishing a biobank and statistical analysis planAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
Acta Anaesthesiologica Scandinavica|March 30, 2026
Adverse Effects Associated With Spinal Versus General Anaesthesia for Hip and Knee Arthroplasties: Protocol for a Systematic ReviewAnne Sofie Nautrup Therkelsen, Hans Bredgaard Christensen, Anne-Lene Kjældgaard, et al.
Journal of Inflammation Research|April 1, 2021
Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort StudyAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
BMC Neurology|April 18, 2021
Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort studyAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
The New England Journal of Medicine|June 29, 2012
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsisAnders Perner, Nicolai Haase, Anne B Guttormsen, et al.
Trials|January 29, 2011
Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trialAnders Perner, Nicolai Haase, Jørn Wetterslev, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Immunology|June 24, 2018
Amyotrophic lateral sclerosis: The complement and inflammatory hypothesisAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
BMJ Open|August 8, 2020
Amyotrophic lateral sclerosis and the innate immune system: protocol for establishing a biobank and statistical analysis planAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
Acta Anaesthesiologica Scandinavica|March 30, 2026
Adverse Effects Associated With Spinal Versus General Anaesthesia for Hip and Knee Arthroplasties: Protocol for a Systematic ReviewAnne Sofie Nautrup Therkelsen, Hans Bredgaard Christensen, Anne-Lene Kjældgaard, et al.
Journal of Inflammation Research|April 1, 2021
Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort StudyAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
BMC Neurology|April 18, 2021
Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort studyAnne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, et al.
The New England Journal of Medicine|June 29, 2012
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsisAnders Perner, Nicolai Haase, Anne B Guttormsen, et al.
Trials|January 29, 2011
Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trialAnders Perner, Nicolai Haase, Jørn Wetterslev, et al.
Pageof 1